New research into stem cell mutations could improve regenerative medicine

18th May 2020

Research from the University of Sheffield has given new insight into the cause of mutations in pluripotent stem cells and potential ways of stopping these mutations from occurring.

  • New research from the University of Sheffield into stem cells could help make regenerative medicine safer
  • Regenerative medicine involves using pluripotent stem cells to repair damaged or diseased tissues in the body
  • The new research has suggested ways to reduce the likelihood of mutations occurring in these cells when cultured

Research from the University of Sheffield has given new insight into the cause of mutations in pluripotent stem cells and potential ways of stopping these mutations from occurring.

The findings, published in Stem Cell Reports, show that pluripotent stem cells are particularly susceptible to DNA damage and mutations compared to other cells, and this could cause genetic mutations.

Pluripotent stem cells are able to develop into any cell type in the body, and there is considerable interest in using them to produce cells to replace diseased or damaged tissues in applications referred to as regenerative medicine.

One concern for the safety of this is that these cells often acquire recurrent mutations which might lead to safety issues if used in patients.

The researchers have found that these mutations are more likely to occur in a certain point during their cell cycle and have suggested ways of growing the cells to dramatically reduce the susceptibility to DNA damage and potentially the mutations that arise.

Peter Andrews, Professor of Biomedical Science at the University of Sheffield, said:

“Clinical trials of regenerative medicine using cells derived from pluripotent stem cells are now beginning around the world, but there are concerns that mutations in the pluripotent stem cells may risk patient safety. Our results may allow us to significantly reduce that risk.

“Understanding the genetic stability of human pluripotent stem cells is an area developed at the University of Sheffield and one in which we are an international lead.”

The Department of Biomedical Science at the University of Sheffield carries out world-leading research to understand disease, improve treatments, and find potential cures. Researchers work in areas ranging from cell biology and developmental biology to neuroscience and regenerative medicine, with expertise in topics including stem cells and cancer.

 

You might also be interested in

Freeths advises Twenty20 Capital on sale of Halian Group to NES Fircroft

Tue 14th April 2026

Freeths advises Twenty20 Capital on sale of Halian Group to NES Fircroft

Moving Beyond Hype to Practical AI Tools for Small and Medium-Sized Businesses

Mon 13th April 2026

An article by Paul Ridgway breaking down the four types of AI relevant to SMEs: generative, predictive, embedded and automation. A practical article identifying where each creates value and how to move from AI curiosity to confident, structured adoption.

Nominees named for SYCF Community Celebration Awards

Mon 13th April 2026

The shortlist has been revealed for South Yorkshire’s Community Foundation (SYCF) Community Celebration Awards.

Freeths supports RedCat Hospitality

Thu 9th April 2026

Freeths supports RedCat Hospitality